Reviews - Stones and Infections

Epidemiology of urolithiasis in Europe and Latin America

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 23 March 2026
Published: 31 March 2026
181
Views
117
Downloads

Authors

Background: The epidemiology of urolithiasis may vary in different geographical areas in relation to various environmental factors; therefore it is important to review the information on its prevalence and incidence in different countries of the world. The aim of this study was to conduct an updated systematic review and meta-analysis on the prevalence and incidence of urinary calculi in Europe and Latin America.
Methods: Two separate searches were performed on EMBASE and PubMed databases. The MESH terms used were “prevalence”, “incidence”, “epidemiology” “urinary calculi” in title or abstract. Each separate search focused on a specific geographic area: Europe or Latin America, which included Southern America, Central America and the Caribbean. Publications between January 1, 1981, and February 28, 2026 were included. We retrieved 1,234 records in PubMed and 7,140 in EMBASE for Europe and 152 records in PubMed and 963 in EMBASE for Latin America. Two independent reviewers screened articles based on a priori protocol. Studies reporting population-based estimates of urinary calculi prevalence or incidence in children and adults were included. In total, 66 and 17 studies were included in the systematic review for Europe and Latin America, respectively. For Europe, 11 studies reported data on both prevalence and incidence, 24 on prevalence and 31 on incidence. For Latin America, 10 studies reported prevalence data and 7 studies reported incidence data.
Results: Random-effects models using the Freeman-Tukey double-arcsine transformation produced a pooled prevalence of kidney stones in Europe of 7.2% (95% CI, 5.55% to 9.05%). Pooled prevalence was 7.03% (95% CI, 5.14% to 9.18%) in Southern/Mediterranean/Balkan Europe and 7.52% (95% CI, 4.50% to 11.24%) in Central/Northern Europe. Pooled prevalence of kidney stones for studies published before year 2000 was 7.37% (95% CI, 4.53% to 10.81%) and 7.11% (95% CI, 5.31% to 9.15%) for studies published in 2000 and later. A meta-regression model indicated that the prevalence of kidney stones was not detectably different in Northern compared with Southern Europe and in study published before compared with those published after 2000. Pooled prevalence of kidney stones in Latin America was 6.02% (95% CI, 3.58% to 9.03%). Study heterogeneity was deemed as “considerable” either in studies in Europe (I2 = 99.86%, p<0.0001) and Latin America (I2 = 99.09%, p< .0001). The overall risk of bias was low to moderate. Incidence values are highly variable depending on the study design and the populations studied. In 3 studies on pediatric populations, incidence ranged between 1.8 and 6.5 cases per year per 100,000 inhabitants.
Conclusions: The prevalence values of urolithiasis were not different across different areas of Europe and have remained stable over the last 20 years. The prevalence of urolithiasis in Latin America appears to be lower compared to Europe.

Downloads

Download data is not yet available.

1. Trinchieri A. Epidemiology of urolithiasis. Arch Ital Urol Androl 1996;68:203-49.

2. GBD 2021 Urolithiasis Collaborators. The global, regional, and national burden of urolithiasis in 204 countries and territories, 2000-2021: a systematic analysis for the Global Burden of Disease Study 2021. EClinicalMedicine. 2024; 78:102924. DOI: https://doi.org/10.1016/j.eclinm.2024.102924

3. Yao W, Wei X, Jing Q, et al. Epidemiological trends of urolithiasis in working-age populations: Findings from the global burden of disease study 1990-2021. PLoS One. 2025; 20:e0327343. DOI: https://doi.org/10.1371/journal.pone.0327343

4. Zhu X, Zhou Y, Yang X, et al. Global, regional and national burden of paediatric urinary stone disease from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021. BMJ Open. 2025; 15:e098722. DOI: https://doi.org/10.1136/bmjopen-2024-098722

5. Tan S, Yuan D, Su H, et al. Prevalence of urolithiasis in China: a systematic review and meta-analysis. BJU Int. 2024; 133:34-43. DOI: https://doi.org/10.1111/bju.16179

6. Wang W, Fan J, Huang G, et al. Prevalence of kidney stones in mainland China: A systematic review. Sci Rep. 2017; 7:41630. DOI: https://doi.org/10.1038/srep41630

7. Alhakamy M, AlShoaibi I, Abdo B, et al. Prevalence of urolithiasis in adults of the Eastern Mediterranean region: A systematic review and meta-analysis. Urological Science 2025; 36:176-184. DOI: https://doi.org/10.1097/us9.0000000000000076

8. Kassaw AB, Belete M, Assefa EM, Tareke AA. Prevalence and clinical patterns of urolithiasis in sub-saharan Africa: a systematic review and meta-analysis of observational studies. BMC Nephrol. 2024; 25:334. DOI: https://doi.org/10.1186/s12882-024-03780-y

9. Liu Y, Chen Y, Liao B, et al. Epidemiology of urolithiasis in Asia. Asian J Urol. 2018; 5:205-214. DOI: https://doi.org/10.1016/j.ajur.2018.08.007

10. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6: e1000097. DOI: https://doi.org/10.1371/journal.pmed.1000097

11. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021; 88:105906. DOI: https://doi.org/10.1016/j.ijsu.2021.105906

12. Aromataris E, Lockwood C, Porritt K, et al. JBI Manual for Evidence Synthesis. JBI; 2024. DOI: https://doi.org/10.46658/JBIMES-24-01

13. Munn Z, Moola S, Lisy K, et al. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and incidence data. Int J Evid Based Healthc. 2015;13:147-153. DOI: https://doi.org/10.1097/XEB.0000000000000054

14. Tschöpe W, Ritz E, Haslbeck M, et al. Prevalence and incidence of renal stone disease in a German population sample. Klin Wochenschr. 1981; 59:411-2. DOI: https://doi.org/10.1007/BF01698521

15. Vahlensieck EW, Bach D, Hesse A. Incidence, Prevalence and mortality of urolithiasis in the German Federal Republic. Urol Res. 1982; 10:161-4. DOI: https://doi.org/10.1007/BF00255937

16. Ljunghall S, Lithell H, Skarfors E. Prevalence of renal stones in 60-year-old men. A 10-year follow-up study of a health survey. Br J Urol. 1987; 60:10-3. DOI: https://doi.org/10.1111/j.1464-410X.1987.tb09123.x

17. Trinchieri A, Coppi F, Montanari E, et al. Increase in the prevalence of symptomatic upper urinary tract stones during the last ten years. Eur Urol. 2000;37:23-5. DOI: https://doi.org/10.1159/000020094

18. Hesse A, Brändle E, Wilbert D, et al. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol. 2003; 44:709-13. DOI: https://doi.org/10.1016/S0302-2838(03)00415-9

19. Stamatiou KN, Karanasiou VI, Lacroix RE, et al. Prevalence of urolithiasis in rural Thebes, Greece. Rural Remote Health. 2006;6:610. DOI: https://doi.org/10.22605/RRH610

20. Indridason OS, Birgisson S, Edvardsson VO, et al. Epidemiology of kidney stones in Iceland: a population-based study. Scand J Urol Nephrol. 2006; 40:215-20. DOI: https://doi.org/10.1080/00365590600589898

21. Thomas LD, Elinder CG, Tiselius HG, et al. Dietary cadmium exposure and kidney stone incidence: a population-based prospective cohort study of men & women. Environ Int. 2013; 59:148-51. DOI: https://doi.org/10.1016/j.envint.2013.06.008

22. Prezioso D, Illiano E, Piccinocchi G, et al. Urolithiasis in Italy: an epidemiological study. Arch Ital Urol Androl. 2014;86:99-102. DOI: https://doi.org/10.4081/aiua.2014.2.99

23. Cano-Castiñeira R, Carrasco-Valiente J, Pérula-de-Torres LA, et al. Prevalence of renal stones in Andalusian population: results of PreLiRenA study. Actas Urol Esp. 2015; 39:26-31. DOI: https://doi.org/10.1016/j.acuroe.2014.11.012

24. Stritt K, Plouvin M, Estoppey Younes S, et al. Epidemiology and risk factors of urolithiasis: insights from SKIPOGH, a populationbased cohort study in Switzerland. Clinical Kidney J. 2026;19:sfag002. DOI: https://doi.org/10.1093/ckj/sfag002

25. Robertson WG, Peacock M, Baker M, et al. Studies on the prevalence and epidemiology of urinary stone disease in men in Leeds. Br J Urol. 1983; 55:595-8. DOI: https://doi.org/10.1111/j.1464-410X.1983.tb03383.x

26. Torres Ramirez C, Fernandez Morales E, et al. An epidemiological study of renal lithiasis in gypsies and others in Spain. J Urol. 1984; 131:853-856. DOI: https://doi.org/10.1016/S0022-5347(17)50679-5

27. CP Inmark AS de estúdios y Estratégias. Estudio sobre la urolitiasis en España. Asociación española de Urología. Grupo de Urolitiasis. Promotor: Rousaud A. Supervisores: Rousaud A, Pedrajas A, Patrocinio: Centro de estudios Welcome España. CP Inmark SA de Estudios y Estrategias.

28. Coppi F, Trinchieri A, Mandressi A, et al. Epidemiologia della nefrolitiasi in un comune della provincia di Milano. Urologia 1987;54:161-164. DOI: https://doi.org/10.1177/039156038705400209

29. Scott R. Prevalence of calcified upper urinary tract stone disease in a random population survey. Report of a combined study of general practitioners and hospital staff. Br J Urol. 1987; 59:111-7. DOI: https://doi.org/10.1111/j.1464-410X.1987.tb04799.x

30. Nikkilä MT, Pasternack A. Prevalence of urolithiasis in a Finnish district.An epidemiologic study of adults in Tampere. Scand J Urol Nephrol.1988; 22:293-7. DOI: https://doi.org/10.3109/00365598809180802

31. Cappuccio FP, Strazzullo P, Mancini M. Kidney stones and hypertension: population based study of an independent clinical association. BMJ. 1990; 300:1234-6. DOI: https://doi.org/10.1136/bmj.300.6734.1234

32. Borghi L, Ferretti PP, Elia GF, et al. Epidemiological study of urinary tract stones in a northern Italian city. Br J Urol. 1990; 65:231-5. DOI: https://doi.org/10.1111/j.1464-410X.1990.tb14716.x

33. Kurennaia SS, Uzun GV, Gerasimenko AI. The incidence of urolithiasis (based on autopsy data from the Donetsk Province Clinical Hospital). Lik Sprava. 1992;3:77-9.

34. Cirillo M, Laurenzi M, Panarelli W, Stamler J. Urinary sodium to potassium ratio and urinary stone disease. The Gubbio Population Study Research Group. Kidney Int. 1994; 46:1133-9. DOI: https://doi.org/10.1038/ki.1994.376

35. Grases F, Conte A, March JG, et al. Epidemiology of urinary stone disease in the Balearic Islands Community. Int Urol Nephrol. 1994; 26:145-50. DOI: https://doi.org/10.1007/BF02768277

36. Serio A, Fraioli A. Epidemiology of nephrolithiasis. Nephron. 1999; 8:26-30. DOI: https://doi.org/10.1159/000046295

37. Hercberg S, Galan P, Preziosi P, et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2004; 164:2335-42. DOI: https://doi.org/10.1001/archinte.164.21.2335

38. Cappuccio FP, Siani A, Barba G, et al. A prospective study of hypertension and the incidence of kidney stones in men. J Hypertens. 1999; 17:1017-22. DOI: https://doi.org/10.1097/00004872-199917070-00019

39. Tucak A, Kalem T, Cvijetic S, et al. The incidence and risk factors of urolithiasis in active working population of the Osijek community: An epidemiological study Periodicum Biologorum 2000;102:431-435.

40. Rudan I, Padovan M, Rudan D, et al. Inbreeding and nephrolithiasis in Croatian island isolates. Coll Antropol. 2002; 26:11-21.

41. Stasevic Z, Gorgieva GS, Vasic S, et al. High prevalence of kidney disease in two rural communities in Kosovo and Metohia. Ren Fail. 2010; 32:541-6. DOI: https://doi.org/10.3109/08860221003706974

42. Stoller M, Tseng T, Eisner B, et al. Prevalence and concordance rates for urolithiaisis: a study of monozygotic and dizygotic male and female Danish twins. J Urol 2010; 183:e505-6. DOI: https://doi.org/10.1016/j.juro.2010.02.893

43. Croppi E, Ferraro PM, Taddei L, et al. Prevalence of renal stones in an Italian urban population: a general practice- based study. Urol Res. 2012; 40:517-22. DOI: https://doi.org/10.1007/s00240-012-0477-z

44. Arias Vega R, Pérula de Torres LA, Jiménez García C, et al. Comorbidity and socio-demographic factors associated with renal lithiasis in persons aged 40 to 65: A cross-sectional study. Med Clin (Barc). 2017; 149:383-390. DOI: https://doi.org/10.1016/j.medcle.2017.09.017

45. Jovic D, Dimkovic N, Rakocevic I, et al. Prevalence and factors associated with self-reported kidney disease among Serbian adults: Results of 2013 National Health Survey. PLoS One. 2018;13:e0203620. DOI: https://doi.org/10.1371/journal.pone.0203620

46. van de Pol JAA, van den Brandt PA, Schouten LJ. Kidney stones and the risk of renal cell carcinoma and upper tract urothelial carcinoma: the Netherlands Cohort Study. Br J Cancer. 2019; 120:368-74. DOI: https://doi.org/10.1038/s41416-018-0356-7

47. Dolcini J, Chiavarini M, Firmani G, et al. Consumption of bottled water and chronic diseases: a nationwide cross-sectional study. Int J Environ Res Public Health. 2024; 21:1074. DOI: https://doi.org/10.3390/ijerph21081074

48. Szymanski J, Chlosta M, Dudek P, et al. Prevalence, correlates, and treatment behaviors for urolithiasis and renal colic-like pain symptoms at the population level in Poland. Sci Rep. 2025;15:10827. DOI: https://doi.org/10.1038/s41598-025-95504-x

49. Ahlstrand C, Tiselius HG. Renal stone disease in a Swedish district during one year. Scand J Urol Nephrol. 1981; 15:143-6. DOI: https://doi.org/10.3109/00365598109179591

50. Laerum E. Urolithiasis in general practice. An epidemiological study from a Norwegian district. Scand J Urol Nephrol. 1983;17:313-9. DOI: https://doi.org/10.3109/00365598309182138

51. Simon P, Ang KS, Cam G, et al. Epidémiologie de la lithiase calcique dans une région française. Premiers résultats à 4 ans. Presse Med. 1986; 15:1665-8.

52. Power C, Barker DJ, Blacklock NJ. Incidence of renal stones in 18 British towns. A collaborative study. Br J Urol. 1987; 59:105-10. DOI: https://doi.org/10.1111/j.1464-410X.1987.tb04798.x

53. Romero Pérez P, Amat Cecilia M. Epidemiología de la litiasis urinaria en la Comarca de la Marina Alta (Alicante). Actas Urol Esp.1992; 16:455-61.

54. Ripa Saldias L, Delpon Pérez E, Romero Fernández FJ. Epidemiology of urinary lithiasis in la Ribera de Navarra (I). Actas Urol Esp. 1995; 19:459-66.

55. Alapont Pérez FM, Gálvez Calderón J, Varea Herrero J, et al. Epidemiology of urinary lithiasis. Actas Urol Esp. 2001; 25:341-9. DOI: https://doi.org/10.1016/S0210-4806(01)72629-0

56. Aibar Arregui MA, Gutiérrez Samper AP, Rodrigo Val MP, et al. Urolithiasis in the area III of Zaragoza: biochemistry and epidemiology. Actas Urol Esp. 2004;28:661-5. DOI: https://doi.org/10.1016/S0210-4806(04)73157-5

57. Edvardsson V, Elidottir H, Indridason OS, Palsson R. High incidence of kidney stones in Icelandic children. Pediatr Nephrol. 2005;20:940-4. DOI: https://doi.org/10.1007/s00467-005-1861-5

58. Trinchieri A, Cappoli S, Esposito N, Acquati P. Epidemiology of renal colic in a district general hospital. Arch Ital Urol Androl. 2008;80:1-4. DOI: https://doi.org/10.1016/j.acpain.2008.05.015

59. Turney BW, Reynard JM, Noble JG, Keoghane SR. Trends in urological stone disease. BJU Int. 2012; 109:1082-7. DOI: https://doi.org/10.1111/j.1464-410X.2011.10495.x

60. Edvardsson VO, Indridason OS, Haraldsson G, et al. Temporal trends in the incidence of kidney stone disease. Kidney Int. 2013;83:146-52. DOI: https://doi.org/10.1038/ki.2012.320

61. Miloševic D, Batinic D, Turudic D, et al. Demographic characteristics and metabolic risk factors in Croatian children with urolithiasis. Eur J Pediatr 2014; 173:353-359. DOI: https://doi.org/10.1007/s00431-013-2165-6

62. Turney BW, Appleby PN, Reynard JM, et al. Diet and risk of kid ney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Epidemiol. 2014; 29:363-9. DOI: https://doi.org/10.1007/s10654-014-9904-5

63. Neziri AE, Tartari F, Xhani M, et al. Epidemiologic aspects of urolithiasis in our clinical material. HealthMED 2015; 9:523-31.

64. Heers H, Turney BW. Trends in urological stone disease: a 5-year update of hospital episode statistics. BJU Int. 2016; 118:785-789. DOI: https://doi.org/10.1111/bju.13520

65. Ni Raghallaigh H, Radcliffe R, Ali A, Symes A. The changing epidemiology and prevalence of renal tract calculi in England: a tenyear analysis. J Urol. 2016;195:e1072-3. DOI: https://doi.org/10.1016/j.juro.2016.02.2142

66. Rukin NJ, Siddiqui ZA, Chedgy ECP, Somani BK. Trends in upper tract stone disease in England: evidence from the hospital episodes statistics database. Urol Int. 2017; 98:391-396. DOI: https://doi.org/10.1159/000449510

67. Leone A, Fernández-Montero A, de la Fuente-Arrillaga C, et al. Adherence to the Mediterranean dietary pattern and incidence of nephrolithiasis in the Seguimiento Universidad de Navarra followup (SUN) cohort. Am J Kidney Dis. 2017; 70:778-786. DOI: https://doi.org/10.1053/j.ajkd.2017.06.027

68. Edvardsson VO, Ingvarsdottir SE, Palsson R, Indridason OS. Incidence of kidney stone disease in Icelandic children and adolescents from 1985 to 2013: results of a nationwide study. Pediatr Nephrol. 2018; 33:1375-1384. DOI: https://doi.org/10.1007/s00467-018-3947-x

69. Omarova KM, H I, Magomedova M, Ibragimova ES. The evaluation of the impact of quality and microelement composition of drinking water on the incidence of urolithiasis in various regions of Dagestan. Urologiia. 2018; 6:60-65. DOI: https://doi.org/10.18565/urology.2018.6.60-65

70. Robinson C, Shenoy M, Hennayake S. No stone unturned: The epidemiology and outcomes of paediatric urolithiasis in Manchester, United Kingdom. J Pediatr Urol. 2020; 16:372.e1-372.e7. DOI: https://doi.org/10.1016/j.jpurol.2020.03.009

71. Rendina D, D'Elia L, Evangelista M, et al. Strazzullo P/1. Calcif Tissue Int. 2020; 107:446-452. DOI: https://doi.org/10.1007/s00223-020-00737-9

72. Littlejohns TJ, Neal NL, Bradbury KE, et al. Fluid intake and dietary factors and the risk of incident kidney stones in UK biobank: a population-based prospective cohort study. Eur Urol Focus. 2020; 6:752-761. DOI: https://doi.org/10.1016/j.euf.2019.05.002

73. Gadzhiev N, Prosyannikov M, Malkhasyan V, et al. Urolithiasis prevalence in the Russian Federation: analysis of trends over a 15-year period. World J Urol 2021; 39:3939-3944. DOI: https://doi.org/10.1007/s00345-021-03729-y

74. O’Connell C, McGuinness G, Lyons L, et al. Abstract 75. Urolithiasis in Ireland: A picture of prevalence between 2005 and 2018 European Urology Open Science 2021;31:S30. DOI: https://doi.org/10.1016/S2666-1683(21)00241-X

75. Jour I, Lam A, Turney B. Urological stone disease: a 5-year update of stone management using Hospital Episode Statistics. BJU Int. 2022; 130:364-369. DOI: https://doi.org/10.1111/bju.15728

76. Sáenz-Medina J, San Román J, Rodríguez-Monsalve M, et al. Hospitalization burden of patients with kidney stones and metabolic comorbidities in Spain during the period 2017-2020. Metabolites. 2023; 13:574. DOI: https://doi.org/10.3390/metabo13040574

77. Moczeniat G, Jankowski M, Gorynski P, Gujski M. Epidemiological characteristics of 214,063 hospital admissions to adult urological departments in Poland in 2022. Cent European J Urol. 2024; 77:538-546. DOI: https://doi.org/10.5173/ceju.2024.55.R1

78. Pedersen JE, Petersen KKU, Andersen MHG, et al. Non-malignant kidney diseases in Danish firefighters. Occup Environ Med. 2025; 82:423-428. DOI: https://doi.org/10.1136/oemed-2025-110285

79. Zhang J, Luo H, Wu H, et al. The association between domestic water hardness and kidney stone disease: a prospective cohort study from the UK Biobank. Int J Surg. 2025; 111:1957-1967. DOI: https://doi.org/10.1097/JS9.0000000000002198

80. Medina-Escobedo M, Zaidi M, Real-de León E, Orozco-Rivadeneyra S. Prevalencia y factores de riesgo en Yucatán, México, paralitiasis urinaria. Salud Publica Mex. 2002; 44:541-5. DOI: https://doi.org/10.1590/S0036-36342002000600006

81. Plata R, Silva C, Yahuita J, et al. The first clinical and epidemiological programme on renal disease in Bolivia: a model for prevention and early diagnosis of renal diseases in the developing countries. Nephrol Dial 1998; 13:3034-3036. DOI: https://doi.org/10.1093/ndt/13.12.3034

82. Reyes Rabanal L, Mirabal Martínez M, Strusser González R. Comportamiento clínico-epidemiológico de la urolitiasis en un área rural del Caribe. Arch Esp Urol. 2002; 55:527-33.

83. Reyes L, Almaguer M, Castro T, Valdivia J. Estudio clínico-epidemiológico de la urolitiasis en un área urbana caribeña. Nefrologia. 2002; 22:239-44.

84. Pinduli I, Spivacow R, del Valle E, et al. Prevalence of urolithiasis in the autonomous city of Buenos Aires, Argentina. Urol Res. 2006; 34:8-11. DOI: https://doi.org/10.1007/s00240-005-0003-7

85. Bacallao Méndez RA, Obregón Rodríguez M, Mañalich Comas R, et al. Caracterización clínico-epidemiológica de la urolitiasis. Rev Cubana Med 2022; 61:1.

86. Del Real OJ, Arzeno L, Barría S, et al. Prevalencia de litiasis urinaria en una población urbana de Chile. Rev Chil Urol 2023; 88:164-171. DOI: https://doi.org/10.24875/RECHURO.23000038

87. Persaud SA, Jankie S, Andrews R, et al. High self-reported prevalence of kidney stones in Trinidad and Tobago: results of a cross-sectional online survey. Cureus. 2024; 16:e57651. DOI: https://doi.org/10.7759/cureus.57651

88. Basulto-Martínez M, Méndez-Molina R, Mendoza-Arcila ME, et al. Burden, sociodemographic determinants, and risk factors of urinary stone disease in Mexico: a comprehensive study. Urolithiasis. 2025; 54:2. DOI: https://doi.org/10.1007/s00240-025-01903-0

89. Nascimento G, Carneiro R, Vieira R, et al. Incidental urinary lithiasis in patients undergoing computed tomography of the abdomen in a tertiary hospital in developing country. Kidney Int Rep 2024; 9:S1-S662. DOI: https://doi.org/10.1016/j.ekir.2024.02.1378

90. Orta-Sibu N, Lopez M, Moriyon JC, Chavez JB. Renal diseases in children in Venezuela, South America. Pediatr Nephrol. 2002;17:566-9. DOI: https://doi.org/10.1007/s00467-002-0892-4

91. Mora Alvarado DA, Chamizo García H. Exploratory-ecological study on the relationship between the concentration of calcium salts in water for human consumption and the incidence of renal stones in Costa Rica. Rev Costar Salud Publ 2007; 16:13-18.

92. Korkes F, Schor N, Heilberg IP. Epidemiology of stone disease in South America. In JJ Talati et al (eds) Urolithiasis. Springer-Verlag, London 2012, pp.61-66 DOI: https://doi.org/10.1007/978-1-4471-4387-1_7

Korkes F, Silva Ii JL, Heilberg IP. Costs for in hospital treatment of urinary lithiasis in the Brazilian public health system. Einstein (Sao Paulo). 2011; 9:518-22. DOI: https://doi.org/10.1590/s1679-45082011gs2143

93. Silva GR, Maciel LC. Epidemiology of urolithiasis consultations in the Paraíba Valley. Rev Col Bras Cir. 2016; 43:410-415. DOI: https://doi.org/10.1590/0100-69912016006001

94. Abreu Júnior J, Ferreira Filho SR. Influence of climate on the number of hospitalizations for nephrolithiasis in urban regions in Brazil. J Bras Nefrol. 2020; 42:175-181. DOI: https://doi.org/10.1590/2175-8239-jbn-2019-0155

95. Solano C, Tarazona N, del Rio AS, et al. Kidney Stones can be an indicator of systemic and cardiovascular disease: Evidence from the Colombian Nationwide Registry Study. preprint Research Square 2025. DOI: https://doi.org/10.21203/rs.3.rs-8051658/v1

96. Casanova Pardo J, Donoso Díaz C, Cortés Durán P. Tasa de egreso hospitalario por cálculo ureteral, 2020-2024, Chile: un estudio descriptivo: Hospital discharge rate due to ureteral calculi, 2020- 2024, Chile: a descriptive study. Rev Estud Med Sur 2025; 13:21-7. DOI: https://doi.org/10.56754/0718-9958.2025.265

97. Spencer WG. Westminster Hospital: an outline of its history, pp.28-46, Glaisher, London 1924.

98. Civiale J. Traite' de l'affection calculeuse. Crochard, Paris 1838.

99. Yelloly J. Sequel to remarks on the tendency to calculous disease. Phil Trans Roy Soc Lond 1830; 120:415-428. DOI: https://doi.org/10.1098/rstl.1830.0028

100. Andersen DA. A survey of the incidence of urolithiasis in Norway from 1853 to 1960.Journal of Oslo City Hospital 1966; 16:101-147.

101. Hellstrom J. Aetiological and therapeutic experience concerning kidney and ureteric stones. Br J Urol. 1949; 21:9-16. DOI: https://doi.org/10.1111/j.1464-410X.1949.tb10744.x

102. Sallinen A. Some aspects of urolithiasis in Finland. Acta Chir Scand 1959;118:479-487.

103. Grossman W. The current stone wave in Central Europe. Br J Urol 1938; 10:46-54. DOI: https://doi.org/10.1111/j.1464-410X.1938.tb10302.x

104. Davalos A. The rarity of stones in the urinary tract in the wet tropics J Urol 1945; 54:182-185. DOI: https://doi.org/10.1016/S0022-5347(17)70064-X

105. Judd MH, Meyers WC. A report on the incidence of urinary lithiasis in the Canal Zone. J Urol 1947; 58:137-139. DOI: https://doi.org/10.1016/S0022-5347(17)69533-8

CRediT authorship contribution

 

 

Data Availability Statement

All data extracted and materials used for the review are available upon reasonable request from the corresponding author.

How to Cite



Epidemiology of urolithiasis in Europe and Latin America. (2026). Archivio Italiano Di Urologia E Andrologia, 98(1). https://doi.org/10.4081/aiua.2026.15173